EX-3.1 2 g084176_ex3-1.htm EXHIBIT 3.1

 

Exhibit 3.1

 

 

 

  

 

 

 

 

  

 

 

 

 

 

  

 

 

 

IN WITNESS WHEREOF, this Elimination of Certificate of Designation of the Preferences, Rights and Limitations of Series A Preferred Stock of Lipella Pharmaceuticals Inc. has been executed by a duly authorized officer of the Company on this 10th day of April, 2024. 

   
  /s/ Jonathan Kaufman
 

Jonathan Kaufman 

Chief Executive Officer